Literature DB >> 27351172

Hyperkinetic disorders and loss of synaptic downscaling.

Paolo Calabresi1,2, Antonio Pisani2,3, John Rothwell4, Veronica Ghiglieri2,5, Josè A Obeso6,7,8, Barbara Picconi2.   

Abstract

Recent clinical and preclinical studies have shown that hyperkinetic disorders such as Huntington's disease, dystonia and l-DOPA-induced dyskinesia in Parkinson's disease are all characterized by loss of the ability to reverse synaptic plasticity and an associated increase in the excitability of excitatory neuronal inputs to a range of cortical and subcortical brain areas. Moreover, these changes have been detected in humans with hyperkinetic disorders either via direct recordings from implanted deep brain electrodes or noninvasively using transcranial magnetic stimulation. Here we discuss the mechanisms underlying the loss of bidirectional plasticity and the possibility that future interventions could be devised to reverse these changes in patients with hyperkinetic movement disorders.

Entities:  

Mesh:

Year:  2016        PMID: 27351172     DOI: 10.1038/nn.4306

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  100 in total

Review 1.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

2.  Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease.

Authors:  M Tegenthoff; M Vorgerd; F Juskowiak; V Roos; J P Malin
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1996-08

3.  An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice.

Authors:  Mai T Dang; Fumiaki Yokoi; Chad C Cheetham; Jun Lu; Viet Vo; David M Lovinger; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-08       Impact factor: 3.332

4.  Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.

Authors:  G Koch; L Brusa; F Carrillo; E Lo Gerfo; S Torriero; M Oliveri; P Mir; C Caltagirone; P Stanzione
Journal:  Neurology       Date:  2009-07-14       Impact factor: 9.910

Review 5.  The pathophysiological basis of dystonias.

Authors:  Xandra O Breakefield; Anne J Blood; Yuqing Li; Mark Hallett; Phyllis I Hanson; David G Standaert
Journal:  Nat Rev Neurosci       Date:  2008-03       Impact factor: 34.870

6.  Repetitive transcranial magnetic stimulation not beneficial in severe choreiform movements of Huntington disease.

Authors:  Aniket Shukla; Rajan Nishanth Jayarajan; Kesavan Muralidharan; Sanjeev Jain
Journal:  J ECT       Date:  2013-06       Impact factor: 3.635

7.  Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms.

Authors:  Veronica Ghiglieri; Desiree Mineo; Anna Vannelli; Fabrizio Cacace; Maria Mancini; Valentina Pendolino; Francesco Napolitano; Anna di Maio; Manuela Mellone; Jennifer Stanic; Elisabetta Tronci; Camino Fidalgo; Roberto Stancampiano; Manolo Carta; Paolo Calabresi; Fabrizio Gardoni; Alessandro Usiello; Barbara Picconi
Journal:  Neurobiol Dis       Date:  2015-11-27       Impact factor: 5.996

8.  Establishing the definition and inter-rater reliability of cortical silent period calculation in subjects with focal hand dystonia and healthy controls.

Authors:  Teresa Jacobson Kimberley; Michael R Borich; Kristina D Prochaska; Shannon L Mundfrom; Ariel E Perkins; Joseph M Poepping
Journal:  Neurosci Lett       Date:  2009-08-15       Impact factor: 3.046

Review 9.  Motor cortical plasticity in Parkinson's disease.

Authors:  Kaviraja Udupa; Robert Chen
Journal:  Front Neurol       Date:  2013-09-04       Impact factor: 4.003

10.  Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements.

Authors:  Ewgenia Barow; Wolf-Julian Neumann; Christof Brücke; Julius Huebl; Andreas Horn; Peter Brown; Joachim K Krauss; Gerd-Helge Schneider; Andrea A Kühn
Journal:  Brain       Date:  2014-09-10       Impact factor: 13.501

View more
  32 in total

Review 1.  Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

Review 2.  Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities.

Authors:  Barbara Picconi; Elvira De Leonibus; Paolo Calabresi
Journal:  J Neural Transm (Vienna)       Date:  2018-02-28       Impact factor: 3.575

Review 3.  Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.

Authors:  George V Rebec
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

4.  A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys.

Authors:  Goichi Beck; Shunsuke Maehara; Phat Ly Chang; Stella M Papa
Journal:  Mov Disord       Date:  2018-03-06       Impact factor: 10.338

5.  Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.

Authors:  Mariangela Scarduzio; Chelsea N Zimmerman; Karen L Jaunarajs; Qin Wang; David G Standaert; Lori L McMahon
Journal:  Exp Neurol       Date:  2017-06-03       Impact factor: 5.330

Review 6.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

7.  Neurocalcin regulates nighttime sleep and arousal in Drosophila.

Authors:  Ko-Fan Chen; Simon Lowe; Angélique Lamaze; Patrick Krätschmer; James Jepson
Journal:  Elife       Date:  2019-03-13       Impact factor: 8.140

8.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

9.  Biallelic variants in TSPOAP1, encoding the active-zone protein RIMBP1, cause autosomal recessive dystonia.

Authors:  Niccolò E Mencacci; Marisa M Brockmann; Jinye Dai; Sander Pajusalu; Burcu Atasu; Joaquin Campos; Gabriela Pino; Paulina Gonzalez-Latapi; Christopher Patzke; Michael Schwake; Arianna Tucci; Alan Pittman; Javier Simon-Sanchez; Gemma L Carvill; Bettina Balint; Sarah Wiethoff; Thomas T Warner; Apostolos Papandreou; Audrey Soo; Reet Rein; Liis Kadastik-Eerme; Sanna Puusepp; Karit Reinson; Tiiu Tomberg; Hasmet Hanagasi; Thomas Gasser; Kailash P Bhatia; Manju A Kurian; Ebba Lohmann; Katrin Õunap; Christian Rosenmund; Thomas C Südhof; Nicholas W Wood; Dimitri Krainc; Claudio Acuna
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

Review 10.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.